Who Should be Wearing Face Masks?
Rajiv Dhand, MD, discusses the importance of everyone wearing face masks including health care workers seeing patients outside the hospital setting.
Can Baloxavir Limit Spread of Flu Cases Within Families?
New study findings shed light on the positive effects of baloxavir for preventing influenza spread in household settings.
Why is Ebola Endemic to the DRC?
In Mbandaka, an 11th outbreak of Ebola is emerging. This outbreak has renewed questions about what makes the virus such a challenge for Congolese society to reign in.
Is Kawasaki Disease Triggered by Underlying Infection Like COVID-19 or Flu?
Following an outbreak of both COVID-19 and H1N1 influenza, Parisian hospital admissions for Kawasaki disease increased.
Skilled Nursing Facilities Face Spikes in Deaths, Drops in Admissions
Skilled nursing facilities are facing an unprecedented crisis as deaths rise amid the COVID-19 pandemic while admissions and patient census decline, a new study shows.
COVID-19 Vaccine Candidate Induces Immune Response in All Phase 1 Participants
The mRNA-1273 vaccine candidate from Moderna will progress to a phase 3 trial in adults later this summer.
Getting Younger People on PrEP
Why it's critical for the future of HIV prevention for programs like the California PrEP-AP to reach younger at-risk persons now.
Complicating the Coronavirus Lockdown Debate
A modeling study from Imperial College shows the pandemic may have significant effect on mortality among other infectious disease patients.
Unmet HIV Therapy Needs, Cure Research, and Virtual Conferences
In the second segment of the interview, Gilead’s Gelezinuas and SenGupta discuss the areas of unmet HIV therapy needs, cure research, and the benefits of a virtual conference.
C. diff. Infection, Renal Impairment Have Lower Risk of Recurrence if Given Bezlotoxumab
A new study finds patients with Clostridium difficile infection are more likely to face a recurrence of the infection if they also have renal impairment. However, bezlotoxumab can reduce that risk.
COVID-19 Could Raise HIV, TB, Malaria Death Rates
The Social Hurdles of HIV Awareness and Prevention
How a sexually-transmitted virus is hindered by limited marketing, and how its stigmas compare to those developing around COVID-19.
FDA Fast Tracks 2 COVID-19 Vaccines
Pfizer and BioNTech were given approval by the federal agency to expedite their work on investigational vaccines.
Insights into Vesatolimod
Gilead provides some important information on this investigational therapy.
WHO Ebola Virus Disease Definitions Are Suboptimal, Study Shows
Ebola virus disease definitions from the World Health Organization definitions could be improved by including contact history and intense fatigue as a key symptom and excluding fever, a new study found.
'Warp Speed,' Without Cutting Corners on Safety
Efforts to develop a COVID-19 vaccine must not skip important steps during clinical evaluation, experts explain.
NSAIDS, Influenza Hospitalization, and Adverse Outcomes
Is there an association with adverse outcomes in patients hospitalized with influenza taking NSAIDS?
Addressing HIV Stigma in MSM
Why men who have sex with men face social hurdles in seeking PrEP and preventive education.
Evolving PrEP to Patient-Friendly Standards
How regional-based data and advancing preventive options could bolster individual HIV-risk care access.
FDA Cyclospora Outbreak Investigation: 500+ Cases Across 8 States
Mylan Pharmaceuticals also announced that a batch of daptomycin has been recalled due to contamination.
Bringing 2 to 4 Antibiotics for AMR to Market by 2030
Biopharmaceutical companies create nearly $1 billion fund to aid much needed pipeline for antimicrobial resistance.
Remdesivir: Gilead Touts Promising Coronavirus Outcomes Across Race & Ethnicity
Findings were announced during the special COVID-19 sessions of the virtual 23rd International AIDS Conference.
Possibility for C diff Spread in the Home Environment
While household transmission of C diff infection is low, there was increased incidence after a familial exposure.
DAA Therapy for Hepatitis C Is Associated With Lower Disease-Related Costs
This therapy is associated with lower disease-related costs after treatment, but the costs of other conditions may outweigh total cost reductions over time.
Scientists Warn of Greater Airborne Range for SARS-CoV-2
Over 200 scientists issued alert to medical community that COVID-19 is transmissible over longer distances via smaller aerosolized droplets.
Why Fewer At-Risk Men Take HIV PrEP
A study looking at PrEP population obstacles shows men who have sex with men are more likely to not seek out information nor access to prophylaxis.
HIV Screening: Are Primary Care Physicians Following CDC Guidelines?
Dr. Marc Pitasi, epidemiologist, discusses facilitators of routine HIV screening among primary care physicians.
Telehealth Seen as Viable Option for Same-Day ART Patients
A small study shows a majority of HIV patients open to both starting ART and follow-up telehealth appointments.
How California is Improving PrEP Access
A discussion around new data presented at AIDS 2020 which shows statewide strategies are breaking down barriers.
Cash for Clinic Visits: Financial Incentive Boosts HIV Viral Suppression
Investigators in Tanzania trialed modest, automated financial incentives for clinic attendance on viral suppression for patients initiating ART.
